Read More Apparatus Significantly Longer Survival In Refractory Breast Cancer With The Addition Of Eganelisib To Standard Treatment! Nov 06, 2024
Read More Apparatus Heavyweight! First ADC Drug Approved For Hormone Receptor-Positive Breast Cancer! Nov 22, 2024
Read More Medical Neratinib Included In NCCN Guidelines For Specific HER2-Negative Breast Cancers Nov 03, 2024
Read More Apparatus World's 2nd KRAS Inhibitor Approved For Non-Small Cell Lung Cancer With 80% Efficacy! Nov 02, 2024
Read More Apparatus "New 'Breakthrough' Alzheimer's Drug Approved: Slows Brain Decline By 27%, But $26,500/Year Pricing Controversial Nov 10, 2024
Read More Medical Study Shows That a Blood Pressure Drug Combined With Radiotherapy Improves Outcomes In Locally Advanced Pancreatic Cancer Nov 16, 2024
